5 years ago

proactiveinvestors.com.au

Kazia Therapeutics' cancer drug trials lift valuation to $137 million or $2.20 a share, according to Edison

5 years ago

raskmedia.com.au

iSignthis Ltd (ASX:ISX) Shares — What On Earth…

5 years ago

fool.com.au

ALL ORDINARIES finishes higher Monday: 8 ASX shares you missed

5 years ago

moneymorning.com.au

Cann Global Share Price Up 7% With Vietnam Distributorship

5 years ago

fool.com.au

2 ASX shares looking cheap today

5 years ago

thewest.com.au

Australian Potash signs key shipping agreement

5 years ago

thewest.com.au

Rox/Venus intersect high grade gold at Youanmi

5 years ago

thewest.com.au

Strike poised to start vital drawdown phase at Jaws-1

5 years ago

fool.com.au

3 ASX healthcare shares to buy for a healthy portfolio

5 years ago

proactiveinvestors.com.au

Platina Resources highlights potential value of Blue Moon zinc pick-up to portfolio